Blog - Page 3781 of 5383

ThursdaySep 10, 2009 2:36 pm

General Environmental Management, Inc. (GEVI.OB) Offers World-Class Training

General Environmental Management Inc., in addition to providing the many environmental and waste remediation services it is well known for, also offers companies something equally important. The company, through both onsite and online programs, provides extensive training in the many complexities and solutions relating to the handling and processing of waste, including critical aspects involved in dealing with hazardous waste materials. To its own extensive information and training base, GEM adds qualified partners who specialize in Web-based distance learning, allowing training services to be delivered any place, any time, and at any level. Learning solutions can be both Internet and…

ThursdaySep 10, 2009 2:33 pm

New Millennium Bank (NMNB) Reports Loss in Second Quarter

New Millennium Bank reported a loss of $161,000 in its second quarter ending June 30, 2009. The bank had strong growth in total assets, which rose 26.4% to $240.2 million. Net loans also increased by 28.2% to $175.3 million. Chris Van Der Stad, the CEO of New Millennium Bank, said, "While we have experienced some drag on earnings due to the same economic pressures impacting other banks throughout the nation, as well as our prudent reactions to those pressures, our solid capitalization combined with our conservative risk management philosophy and credit underwriting policies have us well positioned for continued success…

ThursdaySep 10, 2009 1:08 pm

BIO-key International, Inc.’s (BKYI.OB) Biometric Technology Selected for Next Generation FBI AFIS System

BIO-key International, Inc., a leader in finger-based biometric identification and wireless public safety solutions, announced earlier today that it has been awarded a contract by Lockheed Martin to provide fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. "This is the most important award the company has ever received and it may be the most important biometric contract ever awarded", stated Mike Depasquale, BIO-key's CEO. The U.S. FBI is regarded as the most discerning and most demanding fingerprint user in the world. According to the press release, the award of the contract was the result of a competitive…

ThursdaySep 10, 2009 12:59 pm

Easy Energy, Inc. (ESYE.OB) Announces Purchase Orders Totaling $700,000

Easy Energy, Inc. today announced that it has signed purchase orders with a purchaser/reseller based in the U.S., and with its distributor in the UK and Ireland. The orders are for the company’s YoGen cell phone charger device. Gross sales revenues for these transactions are expected to total $700,000. "This is the launch of our world-wide marketing vision for the Company. We are very pleased with our immediate success and we look forward to executing our world-wide marketing and sales program. We intend to reach many markets in the U.S. and in Europe and across the globe through traditional electronics…

ThursdaySep 10, 2009 11:20 am

Keep Clenergen Corp. (CRGE.OB) on Radar!

Clenergen Corporation is focused on using a proprietary biomass process to generate renewable electricity. The company has identified two fast growing species of tree and applied a proprietary Tree Adaption Process for rapidly increasing the growth rate 30‐40%. This substantial growth rate will enable the production of an economically viable source of feedstock/biomass for creating a renewable source of electricity. The company anticipates the implementation of a 71MW per hour biomass power plant in Tamilnadu, India, which will be phased over a 42 month period. It is expected that by 2010, the power plant will generate 15MW per hour. Utilizing…

ThursdaySep 10, 2009 10:11 am

Protalix BioTherapeutics, Inc. (PLX) Complex Receives FDA’s Orphan Drug Designation

Earlier today, Protalix BioTherapeutics, Inc. announced exciting news regarding its proprietary plant cell, prGCD. The company has received notice from the U.S. Food and Drug Administration that the Office of Orphan Products Development has granted orphan drug designation to prGCD, which contains an expressed recombinant form of glucocerebrosidase (GCD), for the treatment of Gaucher disease. Gaucher disease is a lysosomal storage disorder resulting from a deficiency or mutation of the GCD enzyme. The disease affects the liver, spleen, bone marrow, and in some cases, the central nervous system. Orphan drug designation is granted to drugs that may potentially provide a…

ThursdaySep 10, 2009 10:09 am

Kaman Corp. (KAMN) Awarded $53 Million Helicopter Contract

Kaman Corp. produces and/or markets widely-used products for various commercial firms and the military. The company announced today that the helicopter division of its subsidiary, Kaman Aerospace, has been awarded a five-year contract with a potential value of $53 million to build composite helicopter blade skins and skin core assemblies for Bell Helicopters. President and CEO of Kaman Corporation, Neal J. Keating, spoke about the contract award, “We are delighted by this opportunity to work with Bell Helicopter in producing world-class rotorcraft. This is further evidence of our ability to leverage our OEM (original equipment manufacturer) capabilities in support of…

ThursdaySep 10, 2009 10:07 am

eDOORWAYS Corp. (EDWY.PK) Explains Their Business Revenue Model

eDoorways Corp. envisions itself as a revolutionary web-based consumer problem solving gateway. The company's goal is to completely change the way that consumers and both on-line and off-line businesses find each other by matching consumer needs with businesses that offer the best possible solutions. Chairman and CEO of eDoorways, Gary Kimmons, recently described the company's business revenue model in a nutshell, “eDoorways will provide a host of attractive free services and features to users that will organically build our platform and provide myriad revenue opportunities.” When the company's SOLVE doorway is launched October 1st, consumers will have free access to…

ThursdaySep 10, 2009 10:04 am

OLB Group, Inc. (OLBG.OB) Launches Aggressive Advertising Campaign

OLB Group, Inc. has been gaining a stellar reputation as an innovative e-commerce service provider that offers software products and services designed to help businesses sell products over the internet. Today, the young company announced they will be offering patented derma-cosmetic products from Leorex Ltd. to its clients for marketing to their end users. To coincide with the previously announced joint venture with Leorex, a new website has been launched utilizing the current platform of e-commerce from ShopFast, OLBG's software platform, at http://www.leorexdirect.com/freetrial.aspx. An integral part of the campaign includes free membership to the Platinum Club, which offers discounts of…

ThursdaySep 10, 2009 7:56 am

ImmunoCellular Therapeutics, Ltd. (IMUC.OB) Enters into Research and License Option Agreement with Roche Group

ImmunoCellular Therapeutics, Ltd., a Los Angeles-based clinical-stage company that is developing immune based therapies for the treatment of brain and other cancers, recently announced that the company has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY). As one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics, Roche Group will pay royalties to ImmunoCellular Therapeutics based on the company’s worldwide sales of ICT-69 products. Under the terms of the agreement, ImmunoCellular Therapeutics will license to Roche the rights to investigate the potential of…

Site Search

Company Search